Peptide agonist of the thrombopoietin receptor as potent as the natural cytokine

Science
S E CwirlaW J Dower

Abstract

Two families of small peptides that bind to the human thrombopoietin receptor and compete with the binding of the natural ligand thrombopoietin (TPO) were identified from recombinant peptide libraries. The sequences of these peptides were not found in the primary sequence of TPO. Screening libraries of variants of one of these families under affinity-selective conditions yielded a 14-amino acid peptide (Ile-Glu-Gly-Pro-Thr-Leu-Arg-Gln-Trp-Leu-Ala-Ala-Arg-Ala) with high affinity (dissociation constant approximately 2 nanomolar) that stimulates the proliferation of a TPO-responsive Ba/F3 cell line with a median effective concentration (EC50) of 400 nanomolar. Dimerization of this peptide by a carboxyl-terminal linkage to a lysine branch produced a compound with an EC50 of 100 picomolar, which was equipotent to the 332-amino acid natural cytokine in cell-based assays. The peptide dimer also stimulated the in vitro proliferation and maturation of megakaryocytes from human bone marrow cells and promoted an increase in platelet count when administered to normal mice.

References

Mar 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·M G CullP J Schatz
Sep 13, 1994·Proceedings of the National Academy of Sciences of the United States of America·L C MattheakisW J Dower
Sep 8, 1995·The Journal of Biological Chemistry·C L MartensC W Smith
Jan 1, 1996·Methods in Enzymology·P J SchatzC M Gates
Jan 1, 1996·Methods in Enzymology·L C MattheakisW J Dower

❮ Previous
Next ❯

Citations

May 8, 2001·International Journal of Cancer. Journal International Du Cancer·M HouimelJ P Mach
May 15, 2002·Electrophoresis·Michael MayerGerard J M Bruin
Jul 17, 2008·Comparative and Functional Genomics·B K Kay
Apr 22, 2005·Apoptosis : an International Journal on Programmed Cell Death·A YoshimoriS Tanuma
Jan 13, 2009·Cytotechnology·Jiansheng Gong, Yoshihiro Ito
Jul 4, 2013·International Journal of Hematology·David J Kuter
Dec 25, 2003·Cytokine·Virginia C Broudy, Nancy L Lin
Nov 5, 2002·Clinical Biochemistry·Hassan M E Azzazy, W Edward Highsmith
Sep 15, 2000·Journal of Immunological Methods·S Moshitch-MoshkovitzE Katchalski-Katzir
Jan 11, 2001·Journal of Immunological Methods·F D'Mello, C R Howard
Jul 10, 1998·Immunology Letters·M AbeY Masuho
Apr 20, 2000·Transfusion Science·E L Snyder
May 7, 1998·Transfusion Science·L A Harker
Jul 27, 1999·Combinatorial Chemistry & High Throughput Screening·G CesareniG Cestra
Dec 23, 1999·Current Opinion in Structural Biology·I A Wilson, L K Jolliffe
Aug 17, 1999·Current Opinion in Structural Biology·R W Roberts, W W Ja
Sep 2, 1999·Current Biology : CB·G Jiang, T Hunter
Apr 20, 2001·Bioorganic & Medicinal Chemistry·D L Boger, J Goldberg
Dec 26, 2001·Cytokine & Growth Factor Reviews·Amy E GeddisKenneth Kaushansky
Sep 21, 2001·Drug Discovery Today·S G. Miller
Jul 11, 2001·Drug Discovery Today·D J. ChristensenP T. Hamilton
May 23, 2002·Current Opinion in Chemical Biology·William J Dower, Larry C Mattheakis
Aug 6, 1998·Current Opinion in Chemical Biology·W J Dower
Nov 10, 1998·Nature Structural Biology·M D Ballinger, J A Wells
Mar 20, 2001·Nature Reviews. Genetics·B R Stockwell
Apr 7, 1998·Nature Biotechnology·T FukumotoK Sugimura
Nov 14, 1997·Nature Biotechnology·A Braisted
Nov 14, 1997·Nature Biotechnology·N C WrightonW J Dower
Apr 3, 2004·Nature Reviews. Drug Discovery·Michelle R Arkin, James A Wells
Oct 5, 2010·Molecular BioSystems·Lingyin LiLaura L Kiessling
Apr 16, 1999·Transfusion·D J KuterJ McCullough
Apr 24, 2001·Transfusion·C C FolmanA E von dem Borne
Apr 19, 2002·Transfusion·David J Kuter
Sep 10, 1998·The New England Journal of Medicine·K Kaushansky
Nov 6, 2009·The New England Journal of Medicine·Iain C MacdougallKai-Uwe Eckardt
Aug 3, 2011·Proceedings of the National Academy of Sciences of the United States of America·Matthew J WebberSamuel I Stupp
Jun 23, 2012·Proceedings of the National Academy of Sciences of the United States of America·Shingo UenoTakafumi Sakai
Mar 31, 1999·Proceedings of the National Academy of Sciences of the United States of America·P R Buseck, M Pósfai

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.